Early adoption of screening and the changing pattern of cervical cancer in UK Military women: evidence from the Scottish Veterans Health Study by Bergman, Beverly P. et al.
  
 
 
 
 
Bergman, B. P., Mackay, D. F., and Pell, J. P. (2016) Early adoption of screening 
and the changing pattern of cervical cancer in UK Military women: evidence from 
the Scottish Veterans Health Study. Journal of the Royal Army Medical Corps, 
162(5), pp. 379-382. 
 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/116146/ 
     
 
 
 
 
 
 
Deposited on: 1 March 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
1 
 
Early Adoption of Screening and the Changing Pattern of Cervical Cancer in UK Military 
Women: Evidence from the Scottish Veterans Health Study 
Short running title:  Cervical cancer in veterans   
Authors:  
 Beverly P Bergman 
 Daniel F Mackay 
 Jill P Pell 
 
 
Dr BP Bergman MB ChB 
Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 8RZ, UK 
b.bergman.1@research.gla.ac.uk 
 
Dr DF Mackay PhD 
Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 8RZ, UK 
Daniel.mackay@glasgow.ac.uk 
 
Prof JP Pell MD 
Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 8RZ, UK 
Jill.pell@glasgow.ac.uk 
 
 
 
Corresponding Author: 
Dr BP Bergman MB ChB 
Institute of Health and Wellbeing 
Public Health & Health Policy 
1 Lilybank Gardens 
Glasgow 
G12 8RZ 
 
Telephone: (++)44 141 330 7173 
Fax: Nil 
E-mail: b.bergman.1@research.gla.ac.uk 
 
Word Count: 2,776 
Keywords: Military veterans; women veterans; cervical cancer; screening; retrospective 
cohort studies 
 
2 
 
ABSTRACT 
Objective 
To examine the risk of cervical cancer in a large national cohort of military veteran women, 
followed up for up to 30 years. 
Methods 
Retrospective cohort study of 5,235 veteran women born 1945-1985, and 20,703 women 
with no record of service matched for age and area of residence, using Cox proportional 
hazard models to compare the risk of cervical cancer, overall and by year of birth.  
Results 
During the follow-up period 1981-2012, there were 18 (0.34%) cases of cervical cancer in 
the veteran women compared with 81 (0.39%) in the non-veterans. The difference was not 
statistically significant overall (adjusted hazard ratio (HR) 0.95, 95% CI 0.57-1.59).  When 
analysed by year of birth, veteran women born in 1958 and earlier had a non-significantly 
higher risk than non-veterans (adjusted HR 1.24, 95% CI 0.68-2.26), whilst veteran women 
born after 1958 had a non-significant reduction in risk (adjusted HR 0.51, 95% CI 0.18-1.44). 
Conclusion 
Women born after 1958 who have served in the Armed Forces are at reduced risk of cervical 
cancer compared with women who have never served, and compared with older veteran 
women. Small numbers of cases precluded statistical significance. The change in risk pattern 
in veteran women coincided with the introduction of cervical screening in the Armed Forces, 
which predated the UK national programme, and provides evidence for the long-term 
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effectiveness of the Armed Forces’ sexual health strategy.  The impact of recent changes in 
the screening age, and of HPV immunisation, should be monitored in the future.  
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KEY/EDUCATIONAL MESSAGES 
• Overall, UK military veteran women are at no greater risk of cervical cancer than 
non-veteran women. 
• Veteran women born 1945-1958 had a higher risk than non-veterans, but the 
reverse is true of veterans born since 1959 although the difference did not reach 
statistical significance.  
• The early introduction of cervical cytology in the Armed Forces (which predated the 
NHS programme), proactive sexual health promotion, and high uptake of screening, 
may be responsible for the changing pattern.   
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INTRODUCTION 
Cervical cancer is the third commonest cancer in women worldwide, although the 
implementation of screening programmes in developed countries has had a major impact 
and in the UK, it ranks only 11th, accounting for 2% of all new cancers in women.  The peak 
incidence is in the 4th decade of life although there is a smaller peak in the 9th decade.  
There is a crude incidence in Scotland of 11 per 100,000, with a lifetime risk of 1 in 112.[1, 2]  
By 2002/04, there had been a 49% reduction in incidence compared with 1985/87, prior to  
the introduction of the UK national screening programme.  More recently, an increase in 
incidence, greatest in women aged 20-34, has been reported and has been mirrored in 
other countries.[3, 4] 
Cervical cytology as a screening tool was developed in the 1920s by Papanicolaou but it was 
not until 1947 that the details of the procedure for sampling the cervix were published.[5]  
Screening was introduced on an ad hoc basis in the UK in 1967,[3] and in 1988 a national 
programme of call and recall was established.[6]  The British Army, which operated a health 
care service independently from the National Health Service (NHS), established its own 
Cervical Cytology Screening Service in 1962, collocated with the Army Histopathology 
Registry at the Royal Army Medical College, Millbank, London.  The Royal Navy and Royal Air 
Force offered similar services.   Initially, screening was only offered to women over 35 years 
of age but in 1967 the service was extended to all women for whom the Army provided 
primary care.[7]   Although there was no formal call/recall system, opportunistic screening 
was widely offered, often in association with contraceptive or sexual health consultations, 
and individual primary care nurses devised and operated local call/recall systems.   
Abnormal results were followed up by the Army Histopathology Registry and, failing receipt 
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of repeat cytology or a biopsy specimen taken in a military hospital, details of follow-up 
elsewhere were required to be submitted.  This system worked surprisingly well and in an 
audit of 748 Army women (serving and dependant) in 1985, Zaklama and Birkett found that 
677 (90%) had undergone screening in the last 5 years.  Four percent had been referred for 
further investigation following an abnormal result.[8]   
The Army Histopathology Registry was disbanded on the closure of the Royal Army Medical 
College in 1997 and the opportunity was taken to establish a Service-wide call and recall 
system in collaboration with the National Health Service (NHS).  After a competitive 
tendering process, Warwickshire Health Authority was selected as the NHS partner,  
although this changed to Coventry and Warwickshire Registration and Screening Service 
following local reorganisation.[9]  The service ‘went live’ in 2001.  Initially, screening was 
offered to all Servicewomen aged 20 years and over although in 2004 the lower age-limit 
was changed to 25 years in line with the recommendations which gave rise to a change in 
national policy in England and Wales.[10]  Servicewomen recruited from Scotland, which 
retained a lower age limit of 20 years, continued to be included in the screening programme 
prior to age 25 years if they had already had their first test prior to joining the Services.    
The service provided to the Armed Forces by the NHS was audited in line with national audit 
policy although the results were reported separately.   Rates of abnormality for the Service 
community were at the upper end of the national range.  Rates of 7% borderline/mild 
abnormality and 2-2.5% moderate/severe abnormality were reported in most editions of  
the Annual Report on the Health of the Army  (an internal Ministry of Defence publication 
by the Army Health Unit) between 2001 and 2006, compared with an average of 5.6-
6.2%/1.3-1.5% nationally (2002-2011)[11] and may be related to exposure to HPV infection 
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owing to the high prevalence of genital warts in the Armed Forces.[12]  Genital warts affect 
as many as 20% of male and 10-15% of female attendees at military sexual health clinics and 
tend to recur at times of stress,[13] especially in relation to overseas deployment.   Overall 
prevalence of genital warts is unknown as military personnel in the UK are able to attend 
NHS sexual health clinics if they prefer.  Catch-up vaccination against HPV is now offered to 
female recruits under the age of 18 years who are not fully immunised on entry.[14] 
The reported prevalence of cytological abnormalities appears to have given rise to a 
perception of high rates of cervical cancer in Servicewomen compared with civilians; in 2013 
a National Screening Audit ‘Q&A’ response reported that “Women in HM forces or in prison are 
at higher risk of developing cervical cancer than the general population, however they are not 
registered with an NHS GP and they do not receive standard NHS screening.”[15]   This is clearly 
misleading as the screening programme offered to Armed Forces women has been identical 
to the NHS programme since 2001.  The Scottish Veterans Health Study provided an 
opportunity to examine whether cervical cancer occurs more frequently in veteran women 
than in those who have never served, and whether the pattern of risk has changed over 
time. 
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METHODS 
Design and participants 
The Scottish Veterans Health study is a retrospective cohort study that comprises all 56,570 
military veterans born between 1945 and 1985 who were registered with NHS Scotland both 
prior to military service and following discharge, and a 3:1 comparison group of 172,753 
individuals with no record of military service matched by age, sex and postcode sector of 
residence (mean population 5,000).  The cohort includes 5,302 female veterans, reflecting 
the sex balance of the Armed Forces, and 20,707 female non-veterans.   The study cohort 
and methods have been described in detail previously.[16]  Participants were identified 
from their electronic NHS registration records, which provided demographic information as 
well as the dates of entering and leaving military service, and socio-economic status was 
categorised by postcode of residence in quintiles derived from the Scottish Index of Multiple 
Deprivation (SIMD).[17] The records were linked, at the individual level, to routine hospital 
admissions data and cancer registrations (Scottish Morbidity Record SMR01 and SMR06), 
and death certificates, to provide information on incidence of cervical cancer and death 
from cervical cancer.  Information was available for follow-up events that occurred between 
1 January 1981 and 31 December 2012 inclusive. The electronic NHS record provided dates 
of entering and leaving the Service for veterans.  The maximum period of follow-up was 
from 1 January 1981 (or date of leaving the Service, for veterans, if later) to 31 December 
2012. The data extract was pseudo-anonymised, and approval for the study was granted by 
the Privacy Advisory Committee of the Information Services Division of NHS Scotland.   
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Statistical analysis 
Cox proportional hazard models were used to examine the association between veteran 
status and cumulative risk of cervical cancer, using age as the time dependent variable, age 
at first record of cervical cancer as the failure time and age at death (if no cervical cancer) as 
the censor time. Cox proportionality assumptions were tested using methodology based on 
Schoenfeld residuals.[18]  The a priori rejection level was set at 0.05. The models were run 
univariately and then repeated adjusting for the potential confounding effect of SES quintile.  
The analyses were repeated stratifying by year of birth to examine potential birth cohort 
effects.  All analyses were performed using Stata v12.1 (©1985-2011 StataCorp).   
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RESULTS 
After data cleansing, 5,235 (98.7%) female veterans and 20,703 (99.9%) female non-
veterans were included in the analysis. Among the veteran women, 60% had left the Armed 
Forces by the age of 25 years, while over 80% had left by 30 years of age; the median length 
of service was 3.9 years (IQR 1.3-7.5 years).  
 During the period of follow-up, from 1 January 1981 to 31 December 2012, there were 18 
(0.34%) cases of cervical cancer in veteran women, compared with 81 (0.39%) in non-
veteran women. The mean length of follow-up in veterans with cervical cancer was 12.6 
years (SD 8.7), giving a total of 227 woman-years of follow-up, compared with 12.1 years 
(SD 8.9) equating to 979 woman-years of follow-up in non-veterans. 
The overall difference in risk was not statistically significant in the Cox model when veterans 
were compared with non-veterans, unadjusted hazard ratio (HR) 0.97, 95% CI 0.58-1.61, 
p=0.906.  The difference was similar after adjusting for socio-economic status, HR 0.95, 95% 
CI 0.57-1.59, p=0.853.  Visual inspection of the data by year of birth (Figure 1) indicated a 
substantial reduction in incidence in veteran women born after 1958 compared with those 
born in earlier years.   For women born 1945-1958, there were 14/2,015 (0.69%) cases of 
cervical cancer in the veterans compared with 45/8,036 (0.56%) in non-veterans, unadjusted 
HR 1.31, 95% CI 0.72-2.40, p=0.372, adjusted HR 1.24, 95% CI 0.68-2.26, p=0.480.  For 
women born between 1959 and 1985, the corresponding numbers of cases were 4/3,220 
(0.12%) in the veterans and 36/12,667 (0.28%) in the non-veterans, unadjusted HR 0.51, 
95% CI 0.18-1.43, p=0.202, adjusted HR 0.51, 95% CI 0.18-1.44, p=0.206, representing a 
reduction of 83% in the veteran women and 50% in the non-veterans in the 1959-1985 birth 
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cohort in the adjusted hazard ratios, compared with the earlier birth cohort. Despite the 
apparent large reduction in incidence of cervical cancer in women veterans born since 1958 
compared with non-veterans, the difference did not achieve statistical significance as the 
small overall number of cases gave insufficient statistical power, OR 0.44, 95% CI 0.16-1.23, 
p=0.106.  In the Cox proportional hazard model, comparing the 1959-1985 birth cohort with 
the 1945-1958 birth cohort, the unadjusted hazard ratios were HR 0.33, 95% CI 0.10-1.07, 
p=0.064 for veterans and HR 0.81, 95% CI 0.50-1.30, p=0.376 for non-veterans.  The 
difference reduced slightly after adjusting for deprivation, HR 0.39, 95% CI 0.12-1.27, 
p=0.120 for veterans and HR 0.85, 95%CI 0.53-1.38, p=0.512 for non-veterans, but the 
reduction in risk in veterans in the later birth cohort remained apparent although it did not 
achieve statistical significance.  
There was one death from cervical cancer in the veterans (4.4 per 1,000 woman-years), 
equating to a crude case-fatality rate of 5.6%, compared with 8 deaths in the non-veterans 
(8.2 per 1,000 woman-years), equating to a crude case fatality rate of 9.9%.  
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DISCUSSION 
Main findings 
Data from the Scottish Veterans Study has demonstrated that overall, military veteran 
women were at no greater risk of cervical cancer than women who had never served, but 
the risk has changed over time.  Veteran women in the earlier birth cohort (1945-1958) 
demonstrated a non-significantly higher risk of cervical cancer than non-veterans, but there 
was a greater reduction in risk in veterans born after 1958 than in matched non-veteran 
women.    However, absolute numbers of cases were small and the difference did not 
achieve statistical significance.   
Interpretation 
The majority of women born after 1958 joined the Services from 1976 onwards, at a time 
when the military cervical cytology service was well established and available to all women 
registered with an HM Forces primary care practice.   Although screening was always subject 
to informed consent, anecdotal recollections suggest that refusal was almost unknown.  The 
results of this study indicate that the widespread acceptance of screening reported by 
Zaklama and Birkett[8] was highly effective in preventing later cervical cancer in veterans, 
whether by timely treatment and follow-up of pre-invasive disease or by inculcating a 
culture of regular screening from an early age in a group who, as fit young Servicewomen, 
were highly motivated to maintain their health. 
The majority of Servicewomen in our cohort left the Armed Forces after a short period of 
service.  Thus, for veterans resident in Scotland, ascertainment of cases of cervical cancer, 
with a peak incidence in the 4th decade, is likely to be reasonably complete, with few cases 
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missed as a result of having occurred whilst still serving.  Data obtained from Defence 
Statistics (Health) in a Freedom of Information enquiry show that between 1 April 1991 and 
31 December 2012, only 4 cases of cervical cancer occurred in the 2,463 women throughout 
the UK followed up from the Gulf and Era cohorts who were serving at the time of the 1991 
Gulf War, most of whom will have become veterans in the intervening 21 years to the end 
of follow-up.  An estimated 10% of all UK veterans are resident in Scotland; under-
ascertainment in the Scottish veterans cohort is therefore unlikely.    
A consequence of raising the age at entry to the screening programme to 25 years has been 
that many women now leave the Services prior to having their first smear, and thus do not 
have the opportunity to establish a pattern of regular screening during the period when the 
ready availability and good uptake of contraceptive services and sexual health advice in the 
Armed Forces provide a valuable opportunity for health promotion.  Whilst there is no 
evidence that a lack of screening in younger women results in harm,[19] uptake of screening 
after leaving the Services may be now reduced in comparison with previous years when a 
pattern of screening was usually established whilst serving.   No conclusions can yet be 
drawn as to whether this will have any impact on cervical cancer rates in veterans, although 
the recent promotion of HPV vaccination will have a confounding effect on the results of 
future research. 
Previous Studies 
A review of the literature reveals a paucity of studies on cervical cancer in veterans.  A US 
Department of Veterans Affairs study examined 4,140 female Vietnam veterans and a 
similar number of female veterans who had not served in Vietnam and found no difference 
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in their rate of cervical cancer, OR 1.11, 95% CI 0.74-1.66.[20] For active duty personnel in 
the US, Yamane found an increased standardised incidence ratio of 3.19, 95% CI 2.74-3.70, 
for cervical cancer compared with the US population for the period 1989-2002,[21] but in 
contradiction, Zhu found no significant difference for those of white ethnicity with an 
incidence rate ratio (IRR) of 0.92, 95% CI 0.75-1.11, and a reduction in risk for those of black 
ethnicity, IRR 0.43, 95% CI 0.28-0.62, using Defence-wide and national data covering the 
period 1990-2004.  There was a non-significant decline in incidence in white military women, 
compared with a significant decline in national incidence.[22]  Data from our study indicate 
that military service reduces the risk of cervical cancer in women born after 1958, the 
incidence of cervical cancer in this group having fallen further than in the non-veteran 
women. 
Strengths and limitations 
The strengths of the present study are that it was based on a large cohort covering the 
whole of Scotland over more than 30 years of follow-up.  The majority of the women 
reached the peak age for cervical cancer incidence during the study follow-up period, even if 
they had been serving in the Armed Forces.   Since the diagnosis of cervical cancer was 
taken from hospital admission, cancer registration and death records, it is likely to be both 
reliable and reasonably complete in respect of those events occurring within Scotland.  The 
use of record linkage to analyse individual level data directly derived from health records 
allowed a robust cohort study design to be employed.   We were able to adjust the results 
for socioeconomic status.  For women who are military veterans, we have been able to 
access follow-up data from the Gulf Veterans study which has provided a further estimate of 
cervical cancer rates in Servicewomen and veterans. 
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Limitations of the study include loss to follow-up of subjects due to migration away from 
Scotland, which could not be quantified, and the lack of any follow-up data prior to 1 
January 1981 although as the oldest of the cohort were only aged 36 years at that date, the 
number having been diagnosed with cervical cancer by then is likely to be small.    Women 
with Reserve service only were not separately identifiable in the electronic record and were 
therefore included with the non-veterans. They receive screening from the NHS and the 
effect will have been to reduce the apparent magnitude of any differences associated with 
military service. Because of very small numbers of cases, the results, although indicating a 
difference between veterans and non-veterans and a changing pattern over time, did not 
achieve statistical significance.  
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CONCLUSION 
Female veterans born since 1958 have a reduced risk of cervical cancer compared with age 
matched civilians with no record of military service, notwithstanding the higher rate of 
cytological abnormalities in serving women reported elsewhere, although the overall 
number of cases was small and the reduction in risk was not statistically significant.   
Although the risk has fallen in both veteran and non-veteran women when those born after 
1958 are compared with women born 1945-1958, the reduction was greater in the veterans.  
Active promotion and delivery of screening, high uptake and opportunistic sexual health 
promotion in Service primary care are all likely to have been contributory factors.   The 
impact of having raised the age of entry to the screening programme in 2004, resulting in 
many women now leaving the Services prior to becoming eligible for screening, should be 
examined in the future, as these women approach the peak age of incidence of cervical 
cancer.  
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FIGURE LEGEND  
Figure 1 – Cumulative incidence of cervical cancer by year of birth – veterans and non-
veterans 
 
 
Dashed line represents upper boundary of 1945-1958 birth cohort 
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